X4 Pharma stockholders approve reverse stock split; ratio 1:15 to 1:30 to be set by board

X4 Pharmaceuticals, Inc

Special meeting held April 17, 2025; ~79% of outstanding shares (137.2M of 173.7M) present, forming quorum.
Reverse split approved: 113.0M FOR, 24.0M AGAINST, 224k abstentions; no broker non-votes.
Amendment authorizes board to set exact ratio between 1-for-15 and 1-for-30.
Related Proposal 2 was not presented because Proposal 1 passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.